,index,PatientGuid,DiagnosisGuid,ICD9Code,DiagnosisDescription,StartYear_y,StopYear,Acute
0,172556,E5CB2ACC-7D51-4299-BC67-EBA9A32A4AAE,3C604EE4-3F80-4687-AFD9-0670CCC05227,250.02,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type uncontrolled without mention of complication,2010.0,,0
0,172598,E5CB2ACC-7D51-4299-BC67-EBA9A32A4AAE,EE624A89-4CC0-48D3-A833-31E929C5A8C5,272.4,Other and unspecified hyperlipidemia,,,0
0,172626,E5CB2ACC-7D51-4299-BC67-EBA9A32A4AAE,7474D7B6-D53B-4D82-8F13-6076E8B397B6,110.5,Dermatophytosis of the body,2011.0,,0
0,172633,E5CB2ACC-7D51-4299-BC67-EBA9A32A4AAE,FF4CA426-E4A6-4B49-9455-6CF29E3C06A2,790.93,Elevated prostate specific antigen [PSA],,,0
0,172640,E5CB2ACC-7D51-4299-BC67-EBA9A32A4AAE,78A0910B-40E3-4569-A7FF-D9B088C71AD9,389.00,Conductive hearing loss unspecified,2010.0,2010.0,0
0,172647,E5CB2ACC-7D51-4299-BC67-EBA9A32A4AAE,5B22D3CA-7705-4110-AA12-FF4B90F71BEC,380.4,Impacted cerumen,2010.0,,0
0,172654,E5CB2ACC-7D51-4299-BC67-EBA9A32A4AAE,C2F197E0-99BB-457A-BFFE-ACC535344D34,401.9,Unspecified essential hypertension,,,0
